The benfotiamine group had a 43% lower increase in ADAS-cog scores (P = 0.125) than the placebo group, indicating nearly statistically significant less cognitive decline [ 38 ].
1
—
—
The benfotiamine group had a 43% lower increase in ADAS-cog scores (P = 0.125) than the placebo group, indicating nearly statistically significant less cognitive decline [ 38 ].